Find Iadademstat manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Ory-1001 free base, Iadademstat [inn], 1431304-21-0, Chembl3781751, 1431304-21-0 (free base), 54t74394f8
Molecular Formula
C15H22N2
Molecular Weight
230.35  g/mol
InChI Key
ALHBJBCQLJZYON-PFSRBDOWSA-N
FDA UNII
54T74394F8

Iadademstat
Iadademstat is an orally available inhibitor of lysine specific histone demethylase 1 (KDM1A; LSD1), with potential antineoplastic activity. Upon administration, iadademstat binds to and inhibits LSD1, a demethylase that suppresses the expression of target genes by converting the di- and mono-methylated forms of lysine at position 4 of histone H3 (H3K4) to mono- and unmethylated H3K4, respectively. LSD1 inhibition enhances H3K4 methylation and increases the expression of tumor suppressor genes. This may lead to an inhibition of cell growth in LSD1-overexpressing tumor cells. In addition, LSD1 demethylates mono- or di-methylated H3K9, which increases gene expression of tumor promoting genes; inhibition of LSD1 promotes H3K9 methylation and decreases transcription of these genes. LSD1, an enzyme belonging to the flavin adenine dinucleotide (FAD)-dependent amine oxidase family, is overexpressed in certain tumor cells and plays a key role in in the regulation of gene expression, tumor cell growth and survival.
1 2D Structure

Iadademstat

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-N-[(1R,2S)-2-phenylcyclopropyl]cyclohexane-1,4-diamine
2.1.2 InChI
InChI=1S/C15H22N2/c16-12-6-8-13(9-7-12)17-15-10-14(15)11-4-2-1-3-5-11/h1-5,12-15,17H,6-10,16H2/t12?,13?,14-,15+/m0/s1
2.1.3 InChI Key
ALHBJBCQLJZYON-PFSRBDOWSA-N
2.1.4 Canonical SMILES
C1CC(CCC1N)NC2CC2C3=CC=CC=C3
2.1.5 Isomeric SMILES
C1CC(CCC1N)N[C@@H]2C[C@H]2C3=CC=CC=C3
2.2 Other Identifiers
2.2.1 UNII
54T74394F8
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Ory-1001 Free Base

2. Iadademstat [inn]

3. 1431304-21-0

4. Chembl3781751

5. 1431304-21-0 (free Base)

6. 54t74394f8

7. Rg-6016

8. N-[(1r,2s)-2-phenylcyclopropyl]-1,4-cyclohexanediamine

9. 4-n-[(1r,2s)-2-phenylcyclopropyl]cyclohexane-1,4-diamine

10. Trans-n1-((1r,2s)-2-phenylcyclopropyl)-1,4-cyclohexanediamine

11. Trans-n1-((1r,2s)-2-phenylcyclopropyl)cyclohexane-1,4-diamine

12. 1,4-cyclohexanediamine, N1-((1r,2s)-2-phenylcyclopropyl)-, Trans-

13. Ory1001

14. Starbld0049467

15. Iadademstat [who-dd]

16. Gtpl8390

17. Chembl3906257

18. Chembl5028924

19. Schembl14880401

20. Schembl14880402

21. Schembl14880654

22. Bdbm254603

23. Unii-54t74394f8

24. Bdbm50155773

25. Nsc806812

26. Rg6016

27. Zinc94088493

28. Nsc-806812

29. Ncgc00480828-02

30. Ncgc00480828-04

31. Us9469597, 4

2.4 Create Date
2013-06-11
3 Chemical and Physical Properties
Molecular Weight 230.35 g/mol
Molecular Formula C15H22N2
XLogP32.1
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count2
Rotatable Bond Count3
Exact Mass230.178298710 g/mol
Monoisotopic Mass230.178298710 g/mol
Topological Polar Surface Area38 Ų
Heavy Atom Count17
Formal Charge0
Complexity239
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty